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ABSTRACT
Low cancer awareness contributes to delay in presentation for cancer symptoms and 
may lead to delay in cancer diagnosis. The aim of this study was to review the evidence 
for the effectiveness of interventions to raise cancer awareness and promote early 
presentation in cancer to inform policy and future research. We searched bibliographic 
databases and reference lists for randomised controlled trials of interventions delivered 
to individuals, and controlled or uncontrolled studies of interventions delivered to 
communities. We found some evidence that interventions delivered to individuals 
modestly increase cancer awareness in the short term and insufficient evidence that 
they promote early presentation. We found limited evidence that public education 
campaigns reduce stage at presentation of breast cancer, malignant melanoma and 
retinoblastoma.
2
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.3
81
5.
1 
: P
os
te
d 
30
 S
ep
 2
00
9
Confidential draft, please do not disseminate. 1st September 09
Key words: Cancer awareness; Cancer knowledge; Delay; Complex interventions; 
Early presentation; Health service utilisation
3
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.3
81
5.
1 
: P
os
te
d 
30
 S
ep
 2
00
9
Confidential draft, please do not disseminate. 1st September 09
INTRODUCTION
Late stage at diagnosis is a major factor accounting for survival differences between 
European countries for several cancers (Gatta et al, 2000; Sant et al, 2003; Sant et al,  
2007). For some cancers, for example, breast, late stage at diagnosis has been shown 
to contribute to the difference in survival between rich and poor (Downing et al, 2007) 
and black and white women (Jack et al, 2009).
Patient  delay  in  presenting  for  medical  help  after  symptom discovery  is  likely  to 
contribute  to  late  stage  at  diagnosis.  Low cancer  awareness  (which  may  include 
knowledge or beliefs about cancer symptoms, risk of developing cancer, risk factors, 
effectiveness of treatment or effectiveness of strategies for early detection) is a risk 
factor for patient delay (MacDonald et al, 2004; Ramirez et al, 1999). 
In  2003,  the Department of  Health commissioned a systematic review of  evidence 
about factors influencing delay in cancer diagnosis. While not its main focus, it included 
studies examining effectiveness of  interventions to reduce patient  delays in cancer 
diagnosis (MacDonald et al, 2004). It concluded that there had been little research in 
this area but that public cancer awareness campaigns had been associated with some 
improvements in awareness and diagnosis of cancer but that the long-term benefits 
were unclear. 
The  lack  of  evidence  about  the  effectiveness  of  interventions  to  promote  cancer 
awareness and early presentation is hampering development of policy and local action. 
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The aim of this study was to examine the evidence of effectiveness of interventions to 
raise  cancer  awareness and  promote  early  presentation  with  cancer  symptoms to 
inform policy and future research.
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METHODS
Search strategy
We searched the peer-reviewed literature published in English for studies examining 
the  effectiveness  of  interventions  to  increase  cancer  awareness or  promote  early 
presentation. We searched the Cochrane Library; Medline; EMBASE; and PsychINFO 
from 2000 to November 2008 (see Appendix A for search strategy). Two reviewers 
identified  relevant  studies  from  titles  and  abstracts;  a  third  reviewer  resolved 
disagreements. We checked the reference lists of identified reports for further relevant 
studies. 
Study selection criteria
We included studies examining interventions in any population except those targeting 
only people at  high genetic risk or aiming to increase cancer awareness in health 
professionals  exclusively.  We searched for  studies  examining effectiveness  of  two 
types of intervention:
• Interventions  delivered  to  identified  individuals  recruited  to  a  study  which 
attempted to collect outcome data from those individuals after the intervention, 
for example, a one-to-one interaction with a health professional, or a leaflet 
given or posted to an identified individual (‘individual-level interventions’);
• Interventions delivered to communities in which researchers did not control or 
identify  which  individual  received  the  intervention,  for  example,  media 
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campaigns; leaflets distributed indiscriminately at a health club; street stalls with 
posters  and  leaflets  to  promote  early  presentation  (‘community-level 
interventions’).
For individual-level interventions, we searched for randomised controlled trials in which 
the  comparator  was  placebo,  no  intervention  or  usual  care.  We excluded  studies 
comparing two different interventions, or variants of an intervention.
For  community-level  interventions,  we  searched  for  controlled  trials  (with 
contemporaneous  controls,  randomised  or  non-randomised,  with  comparator  no 
intervention) and uncontrolled studies that collected data on outcomes before-and-after 
the  intervention.  This  was  to  acknowledge  that  evaluating  community-level 
interventions  in  randomised  controlled  trials  is  difficult  and  that  policy  on 
implementation of these is often made on the basis of less rigorous evaluations.
We  categorised  each  type  of  study  by  whether  the  outcome  related  to  cancer 
awareness or early presentation. We included studies with any one of the following 
cancer awareness outcomes: knowledge or beliefs about cancer symptoms, what to 
look for when detecting a change that might be cancer, risk of cancer, cancer risk 
factors, effectiveness of cancer treatment if given early, or natural history or prognosis 
of cancer; attitudes towards early detection behaviours and help-seeking; or confidence 
to detect a change that might be cancer. We included studies with any one of the 
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following outcomes that might reflect early presentation: time from symptom discovery 
to presentation or diagnosis; stage of disease at diagnosis; or survival/mortality. 
We excluded studies examining exclusively any of the following outcomes: knowledge 
of  or  beliefs  about:  nature  of  treatment  for  cancer,  cancer  screening,  or  checking 
behaviours (for example, checking breasts, testicles or skin); health-checking behaviour 
(for example, frequency of or competency in breast, testicular or skin self-examination); 
intentions  to  take  up  screening;  or  screening  uptake.  We  excluded  studies  with 
composite outcomes including the outcomes of interest, where these were not reported 
separately.
We also excluded studies in which the only post-intervention outcome measure was 
taken on the same day the intervention was delivered (see Appendix B for summary of 
inclusion and exclusion criteria).
Two reviewers independently extracted data from all papers identified as potentially 
relevant  onto  a  data  extraction  form  (Appendix  C).  Two  reviewers  independently 
applied the inclusion criteria and a third reviewer resolved disagreements.
Quality assessment
The quality of randomised controlled trials eligible for inclusion in the review was scored 
using a methodology checklist developed previously by members of the review team 
(Goldsmith et al, 2006) (Appendix D provides the form used by reviewers to measure 
quality).  Each criterion on the checklist was assessed as  well covered, adequately 
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addressed, poorly  addressed, not  reported or  not  applicable.  The  methodological 
quality of each study was then rated as: ++ (all  or most of the criteria have been 
fulfilled), + (some of the criteria have been fulfilled) or – (few or no criteria have been 
fulfilled). We did not formally score quality of studies of community-level interventions.
Data synthesis
We conducted non-quantitative synthesis of evidence by preparing tables summarising 
the results of studies for each of the main outcomes of interest.
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RESULTS 
The search strategy identified 2557 abstracts. Of these, 90 were identified as meeting 
the criteria and we obtained full text versions of these reports. We subsequently found 
that 42 of these were not relevant. We excluded three out of the remaining 48 reports 
because the  outcomes did  not  meet  the  inclusion  criteria.  This  left  35  studies  of 
individual-level  interventions  and  ten  of  community-level  interventions.  From  the 
individual level interventions, we excluded 18 because outcomes were measured on 
the  same  day  as  the  delivery  of  the  intervention,  seven  because  they  were  not 
randomised controlled trials and five because the studies compared interventions with 
other interventions, rather than no intervention or usual care (Figure 1). 
Individual-level interventions
We found five randomised controlled trials of individual-level interventions examining 
cancer awareness outcomes and none examining early presentation outcomes.
Description of studies and interventions
The  five  randomised  controlled  trials  were  carried  out  in  the  UK,  US  and  the 
Netherlands, and are described in Table 1. Two were cluster randomised controlled 
trials (Boundouki et al, 2004; Glazebrook et al, 2006). The trials focused on all cancers 
(de Nooijer et al, 2004), prostate cancer (Wilt et al, 2001), breast cancer (Rimer et al, 
2002), oral cancer (Boundouki et al, 2004) and malignant melanoma (Glazebrook et al, 
2006). Four of the trials examined the effectiveness of written information compared 
10
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.3
81
5.
1 
: P
os
te
d 
30
 S
ep
 2
00
9
Confidential draft, please do not disseminate. 1st September 09
with no written information, either sent by post (de Nooijer  et al,  2004; Rimer  et al, 
2002; Wilt et al, 2001) or given out in a waiting room (Boundouki et al, 2004). In one 
trial, the written information was supplemented by telephone counselling in a third arm 
(Rimer et al, 2002). Another trial examined the additional effect of tailoring the postal 
information to individual knowledge and intentions in a third arm (de Nooijer  et al, 
2004).  The  fifth  study  examined  the  effectiveness  of  an  interactive  computer 
programme in general practice (Glazebrook et al, 2006). All trials examined knowledge 
outcomes but at different times after the intervention: two weeks (Wilt et al, 2001), three 
weeks (de  Nooijer  et  al,  2004),  eight  weeks (Boundouki  et  al,  2004),  six  months 
(Glazebrook  et al,  2006; de Nooijer  et al,  2004) and 24 months after (Rimer  et al, 
2002). All used different measures of cancer knowledge: three used knowledge scores 
encompassing a range of elements of knowledge (de Nooijer et al, 2004; Glazebrook et  
al,  2006;  Boundouki  et  al,  2004);  one  study  examined  attitudes  towards  paying 
attention to and seeking help for symptoms (de Nooijer et al, 2004); and two used only 
one or two isolated knowledge questions, among other questions relating to screening 
and treatment preferences (Rimer et al, 2002; Wilt et al, 2001). For one of these studies 
(Rimer et al, 2002), this is likely to be because the main aim of the intervention was to 
promote uptake of breast screening, and for the second the main aim was to inform 
decision-making about screening, rather than to promote early presentation (Wilt et al, 
2001).
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Quality of studies
The  quality  of  the  five  trials  was  moderate  to  good.  All  stated  that  they  used 
randomisation  although  only  one  described  how the  randomisation  sequence  was 
generated (Wilt  et al,  2001). The nature of the interventions meant that participants 
could not be kept blind to treatment allocation. None of the trials reported blinding of 
researchers to treatment allocation at the time of outcome data collection or analysis. 
All the studies examined baseline demographic differences between the trial arms and 
all examined change in knowledge or attitude score before and after the interventions 
except for one (Wilt et al, 2001), which examined outcomes only post-intervention. This 
may be important because there were baseline differences between the groups in this 
trial. All the reports reported withdrawals from the trial. The analysis was appropriate for 
most studies, except one cluster randomised controlled trial which did not analyse the 
data using the appropriate method for this design (Boundouki et al, 2004). The other 
cluster  randomised  controlled  trial  used  appropriate  random  effects  modelling 
(Glazebrook et al, 2006).
Findings 
The trials  were heterogeneous in  terms of  nature of  intervention,  populations,  and 
outcomes measured and, therefore, we did not attempt any quantitative synthesis. All 
the  five  trials  found that  the  intervention  increased at  least  one aspect  of  cancer 
awareness, although the effects were fairly modest. The most intensive intervention – 
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tailored  written  information  with  a  reinforcing  newsletter  at  12  months  plus  two 
telephone  counselling  sessions  –  increased  the  proportion  who  gave  the  correct 
answer to a question about age-related risk by 12% compared with usual care after two 
years (Rimer  et al,  2002). Less intensive interventions increased cancer awareness 
more modestly (an interactive computer programme increased the average melanoma 
knowledge  score  by  6% after  six  months  (Glazebrook  et  al,  2006)  and  a  leaflet 
increased average oral cancer knowledge score by 4% after eight weeks (Boundouki et  
al, 2004)). A leaflet about prostate cancer increased the proportion who knew that the 
effectiveness of treatment in early prostate cancer is unknown by 12% after two weeks, 
but the magnitude of this difference may be at least partly due to the short follow-up 
(Wilt  et al,  2001). This trial found that the leaflet did not increase knowledge of the 
natural history of untreated early prostate cancer. 
We found some evidence that tailored print information was more effective than general 
information; tailored information increased average cancer knowledge scores by about 
11% compared with no information and 4% compared with general information after 
three  weeks (de  Nooijer  et  al,  2004).  Tailored  print  information  modified  attitudes 
towards paying attention to and seeking help for symptoms only very modestly (1-2% 
change in average scores) compared with no information (de Nooijer et al, 2004). 
Community-level interventions examining cancer awareness
Description of studies and interventions
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We found four studies examining the effectiveness of community-level interventions 
aiming to increase cancer awareness (Table 2): all were controlled studies but none 
used randomisation (Blumenthal  et al, 2005; Kiekbusch et al, 2000; McCullagh et al, 
2005; Skinner  et al,  2000).  The interventions were: a public education campaign to 
increase  cancer  awareness  in  African-American  communities  in  two  US  cities 
(Blumenthal  et  al,  2005);  an  educational  programme  to  promote  breast  cancer 
awareness  in  African-American  women  in  one  US  city  (Skinner  et  al,  2000);  a 
multimedia programme to promote malignant melanoma knowledge sited in a kiosk in a 
public place in  a Swedish village (Kiekbusch  et al,  2000);  and a health promotion 
initiative  to  promote  testicular  cancer  knowledge  and  self-checking  using  posters, 
leaflets and shower gel in UK workplaces, health clubs and leisure centres (McCullagh 
et al, 2005). 
The studies used different outcome measures, one encompassing knowledge, beliefs 
and attitudes (Blumenthal et al, 2005), the others only knowledge (Skinner et al, 2000; 
Kiekbusch  et al,  2000; McCullagh  et al,  2005); only one used a measure that was 
reported to have been validated (Skinner et al, 2000).
Quality of studies
In  all  the  studies,  the  researchers  selected  controls  appropriately  by  identifying 
communities or sites that were likely to have populations with similar characteristics to 
the intervention communities or sites, but were not likely to be contaminated by the 
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intervention. For two of the studies, (the Swedish study of the melanoma interactive 
multimedia programme (Kiekbusch et al, 2000), and the US study of the breast cancer 
educational programme (Skinner  et al, 2000)), the researchers used only one control 
area. The public  education campaign selected two control  cities (Blumenthal  et al, 
2005) and the UK study of the testicular cancer initiative selected four control sites 
(McCullagh et al, 2005). While the study design in these four studies is stronger than if 
they were uncontrolled, differences between intervention and control areas can give 
rise to spurious findings of effectiveness or lack of effectiveness.
Findings
The studies examining the effectiveness of the public education campaign in the US 
and the effectiveness of the interactive multimedia kiosk in Sweden found no effect on 
knowledge  (Blumenthal  et  al,  2005;  Kiekbusch  et  al,  2000).  The  studies  of  the 
educational  programme for  breast  cancer in  the US and the UK health promotion 
initiative  for  testicular  cancer  found  modest  increases  in  knowledge,  the  first  an 
increase in average breast cancer knowledge score of about 6% after eight months 
(Skinner  et  al,  2000)  and  the  second  an  increase  in  average  testicular  cancer 
knowledge score of 20% after six weeks (McCullagh et al, 2005). 
Community-level interventions examining early presentation outcomes
Description of studies and interventions
15
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.3
81
5.
1 
: P
os
te
d 
30
 S
ep
 2
00
9
Confidential draft, please do not disseminate. 1st September 09
We found six studies; one interrupted time-series analysis (Catalano et al, 2003) and 
five before-and-after studies  (Gabram  et al,  2008; Geczi  et al,  2001; Leander  et al, 
2007; MacKie et al, 2003; Rossi et al, 2000) (Table 3).
The  interrupted  time-series  study  examined  the  effectiveness  of  an  annual  media 
campaign, Breast Cancer Awareness Month, over 23 years in three US cities (Catalano 
et al,  2003).  One before-and-after study examined the effectiveness of  educational 
presentations at a range of sites aiming to downstage breast cancer at the time of 
diagnosis in African-American women in a US city (Gabram et al, 2008). The other four 
studies examined effectiveness of public education campaigns. Two aimed to promote 
early presentation in malignant melanoma: a poster and leaflet campaign in the West of 
Scotland (MacKie  et al, 2003); and a media campaign followed by a leaflet to every 
household inviting every adult with risk factors for a skin check in one city in Italy (Rossi 
et al, 2000). One examined the effectiveness of a national testicular cancer awareness 
campaign  in  Hungary  (Geczi  et  al,  2001)  and  another  a  national  retinoblastoma 
awareness campaign in Honduras (Leander et al, 2007); both used broadcast and print 
media, and seminars and presentations to groups.
Three studies collected outcome data on time from symptom discovery to presentation 
or diagnosis (Geczi et al, 2001; Leander et al, 2007; MacKie et al, 2003). Five studies 
collected stage at diagnosis as an outcome (Catalano et al, 2003; Gabram et al, 2008; 
Leander et al, 2007; MacKie et al, 2003; Rossi et al, 2000).
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Quality of studies
The time-series study was of high quality, the analysis controlling for autocorrelation, 
secular trends and events that might increase detection of all tumours (such as open 
enrolment to health insurance plans) by modelling as a function of the incidence of 
early stage colon cancers in men (Catalano et al, 2003). A before-and-after design is 
often the only feasible design for evaluating public education campaigns although this 
design is intrinsically limited because change in outcome cannot be attributed to the 
intervention alone. However, in four of the before-and-after studies, the outcomes were 
measured soon after the intervention (Gabram et al, 2008; Geczi et al, 2001; Leander 
et al,  2007; Rossi  et al,  2000) so changes are fairly likely to be attributable to the 
intervention. The Scottish melanoma study examined outcomes ten years after the 
intervention (MacKie et al, 2003); however, a study examining earlier outcomes of the 
campaign  suggest  that  the  campaign  immediately  and  significantly  increased  the 
proportion of malignant melanomas with Breslow thickness <1.5mm, and that this was 
sustained during the 1980s (MacKie and Hole, 1992).
Findings
The time-series study found that Breast Cancer Awareness Month, over 23 years led to 
the detection of 790 more early stage (in situ and local (confined to the breast)) breast 
cancers (an average of 34 per year) during the quarters in which the month occurred 
(Catalano et al, 2003). The authors did not report in situ and local cancer separately, 
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nor the proportion identified by screening. The study of educational presentations to 
downstage  breast  cancer  in  African-American  women  found  that  it  reduced  the 
proportion with advanced disease and increased the proportion with very early disease 
(Stage 0) (Gabram et al, 2008). The study of the Italian melanoma campaign found a 
reduction in mean tumour thickness over the period of the campaign compared with the 
four years before (Rossi et al, 2000) and the study of the Scottish  melanoma campaign 
found an increase in the proportion of cases with tumour thickness <1.5mm (MacKie et 
al, 2003). This study also found an increase in the proportion delaying presentation for 
less than three months. The two other studies examining time from symptom discovery 
to diagnosis found that the campaigns had no effect (Geczi et al, 2001; Leander et al, 
2007).  However,  the  Honduran  retinoblastoma  campaign  was  associated  with  a 
reduction in the proportion presenting with advanced disease (Leander et al, 2007). 
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DISCUSSION
Summary of findings
We  found  limited  evidence  to  inform  policy  on  individual-  or  community-level 
interventions to promote cancer awareness. Randomised controlled trials of several 
individual-level interventions, which included written information (tailored and general), 
telephone counselling and a computer interactive programme, found modest positive 
effects on cancer knowledge or attitudes. Follow-up was for six months or less for all 
except one of the trials, so the long-term benefits are not clear. More intensive and 
tailored interventions are likely to be more effective. We found no evidence to inform 
policy on interventions delivered to individuals to promote early presentation. We found 
limited  evidence  of  effectiveness  of  community-level  interventions  (small  group 
educational  programmes and  health  promotion  programmes in  workplaces,  health 
clubs and leisure centres) to promote cancer awareness. We found good evidence that 
Breast Cancer Awareness Month in the US promotes diagnosis of breast cancer at an 
early stage and some evidence that educational interventions by community health 
advocates  and  public  education  campaigns  downstage  breast  cancer,  malignant 
melanoma and  retinoblastoma and  reduce  time  from symptom discovery  to  initial 
presentation in melanoma. Only for the Scottish malignant melanoma campaign did we 
find any evidence that the effect was sustained over a number of years.
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Our systematic review has identified stronger evidence for interventions to promote 
cancer awareness and early presentation than the previous report, which found five 
studies (seven reports) that would have met our inclusion criteria had we extended our 
search  to  studies  published  earlier  (MacDonald  et  al,  2004).  Two  of  the  reports 
examined earlier outcomes of the Scottish melanoma campaign that we have referred 
to above (Doherty and MacKie, 1988; MacKie and Hole, 1992). One study (a controlled 
study  of  a  community-level  intervention  examining  early  presentation  outcomes) 
examined the effectiveness of a cervical cancer group education intervention in rural 
India. The intervention increased the proportion of early cervical cancers diagnosed in 
the  intervention area compared with neighbouring areas (Jayant  et  al,  1995).  The 
remaining  four  reports  examined  three  interventions  aiming  to  increase  malignant 
melanoma  awareness:  one  individual-level  intervention  (an  educational  brochure 
distributed in the workplace to increase knowledge in Australian men aged 45 and 
older)  examined  in  a  randomised  controlled  trial,  which  found  that  it  increased 
knowledge of melanoma compared with no brochure after three months (Hanrahan et  
al, 1995) and two fairly small scale UK public education campaigns, neither of which 
found good evidence of a reduction in tumour thickness after the campaigns, although 
this may have been due to small numbers of incident cancers (Whitehead et al, 1989; 
Graham-Brown et al, 1990; Healsmith et al, 1993). 
Strengths and weaknesses of the review
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Our study brings together the available evidence of effectiveness of interventions to 
promote cancer awareness and early presentation. Our search strategy was pragmatic 
and aimed to be specific but did not include the “grey” literature (that not published in 
peer-reviewed journals).  There is  some evidence that  more comprehensive search 
strategies  have  little  effect  on  the  overall  result  of  systematic  reviews  and  may 
introduce bias by including studies with weaker designs (Egger et al, 2003). However, 
in systematic reviews of social interventions such as public education campaigns or 
health promotion initiatives, searching databases other than the standard biomedical 
ones may uncover important studies (Ogilvie et al, 2005). While we did not search other 
databases, we relaxed our study design inclusion criteria for evaluations of community-
level  interventions,  recognising  that  controlled  trials,  and  particularly  randomised 
controlled trials, are more difficult to carry out.
Searching  databases  for  studies  of  any  kind  of  intervention  to  promote  cancer 
awareness or early presentation is difficult because the search terms cannot focus on 
the intervention itself, unlike a search for studies of the effectiveness of a drug, or a 
particular  type  of  complex  intervention.  A  systematic  review  of  interventions  to 
communicate risk also documented this difficulty (Matthews et al, 1999). It is possible 
that we missed some studies because of the difficulties of designing a search with a 
high level of sensitivity and specificity.
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Knowledge of screening, screening uptake and self-checking behaviour – for example, 
breast checking (including breast self-examination) or testicular checking – may be 
considered to be important elements of cancer awareness. We excluded studies of 
interventions examining only the outcomes of knowledge or uptake of breast or cervical 
screening because these have been covered by other studies (Bonfill Cosp et al, 2001; 
Forbes  et  al,  2001).  We  excluded  studies  examining  outcomes  of  self-checking 
behaviour because the effectiveness of different modes of self-examination has not 
been established.
Strengths and weaknesses of the available evidence
For interventions delivered at an individual level, we found five fairly well-conducted 
randomised controlled trials  examining awareness outcomes. None examined early 
presentation  outcomes.  In  two  of  the  trials,  only  one  or  two  relevant  knowledge 
questions were included as outcomes (Rimer et al, 2002; Wilt et al, 2001) because the 
main aim of the interventions were not,  primarily,  to increase cancer awareness to 
promote early presentation but to promote breast cancer screening in one (Rimer et al, 
2002), and decision-making about prostate cancer screening in the other (Wilt  et al, 
2001).  The other three interventions did aim mainly to increase awareness to promote 
early  presentation,  in  malignant  melanoma  (Glazebrook  et  al,  2006) oral  cancer 
(Boundouki et al, 2004), and a range of cancers (de Nooijer et al, 2004).
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Cancer  awareness  was  measured  in  a  number  of  ways.  Only  one  trial  used  a 
knowledge scale that was reported to have been validated (Boundouki  et al,  2004). 
Because of this and the short follow-up in all  except one trial, it  is not possible to 
assess whether the increases in awareness would be sufficiently comprehensive, large 
or  sustained  to  lead  to  significant  behavioural  change  in  the  event  of  symptom 
discovery. 
One of the difficulties of evaluating community-level interventions using the positivist 
methods  conventional  in  medical  research  is  that  these  methods  are  less  widely 
accepted by social science and health promotion disciplines involved in designing them 
(Green and Tones, 1999; Ogilvie  et al,  2005). Another is that the interventions are 
usually complex (multi-component) and dependent on context, and controlled trials, let 
alone randomised controlled trials, are often very difficult (Thomson et al, 2004). We 
found four controlled studies (not using randomisation) of community-level interventions 
to increase cancer awareness. Interpretation of findings is limited by the relatively weak 
study  design.  The  studies  used a  range  of  outcome measures;  only  one  used a 
measure that was reported to be validated (Skinner et al, 2000). Two studies found no 
significant  effects  on cancer  awareness (Blumenthal  et  al,  2005) (Kiekbusch  et  al, 
2000); whether this is due to intrinsic lack of effectiveness of the interventions, invalid 
outcome measures or to limitations of study design is unknown. Two found increases in 
cancer  awareness:  one  eight  months  after  an  intensive  educational  programme 
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(Skinner et al, 2000) and one six weeks after a poster and leaflet initiative (McCullagh 
et al, 2005). It is likely that the outcomes were attributable to the interventions but we 
cannot be sure of this because of the limitations of study design.
Overall,  community level interventions to promote early presentation provided some 
evidence of  effectiveness  for  breast  cancer,  melanoma and  retinoblastoma.   Five 
studies suggested educational campaigns may lead to downstaging cancer (Catalano 
et al, 2003; Gabram et al, 2008; MacKie et al, 2003; Rossi et al, 2000; Leander et al, 
2007); however, all were uncontrolled so the results cannot be reliably attributed to the 
intervention. On the other hand, outcomes were measured soon after the intervention 
so it is more likely that the improvement can be attributed to it. Another problem with 
interpreting the findings is that it is not possible to attribute the downstaging of cancer 
to the effect of the campaigns on the public only – all the interventions are likely to have 
raised health professional awareness as well; in fact, most were specifically designed 
to do so.
The finding that Breast Cancer Awareness Month (Catalano  et al,  2003) increased 
diagnosis  of  early  stage  tumours  may  be  at  least  partly  due  to  increased 
mammography uptake during the month or soon after, rather than early presentation 
with  symptoms,  so  we  cannot  tell  which  kind  of  behaviour  was  promoted  by  the 
intervention. This is also true of the finding that educational presentations increased the 
proportion with stage 0 breast cancer (Gabram et al, 2008). The benefit of detecting 
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more stage 0/in situ cancers in terms of breast cancer outcomes is unknown, as some 
of the women with these cancers may never have experienced clinical problems, and 
may have received unnecessary investigations. 
Stage at  presentation is  likely  to  be related to  duration of  time between symptom 
discovery and initial presentation but is not necessarily a reliable proxy because stage 
will also be influenced by the grade of the cancer. Few studies examined duration of 
symptoms from discovery to initial presentation (MacKie et al, 2003) (Geczi et al, 2001; 
Leander et al, 2007); two found no effect (Geczi et al, 2001; Leander et al, 2007). It is 
possible that these two studies found no effect on duration of symptoms because the 
campaigns may have advanced both the average date of symptom discovery and the 
average date of presentation – which would lead to presentation at an earlier stage but 
would have no effect on duration of symptoms. 
Implications
We found some evidence that interventions delivered at an individual level can promote 
cancer  awareness over  the  short  term,  but  no evidence that  these promote early 
presentation  with  cancer  symptoms.  Future  research  evaluating  individual-level 
interventions to promote cancer awareness should attempt to use study designs that 
generate high quality evidence, (in other words, randomised controlled trials), measure 
outcomes over a longer term (months/years) and attempt to measure behavioural and 
stage outcomes, as well as knowledge and attitudes. We also highlight the need for 
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standardised and validated measures of cancer awareness for different cancers, similar 
to the Cancer Research UK Cancer Awareness Measure supported by the National 
Awareness and  Early  Diagnosis  Initiative  (Stubbings  et  al,  2009 this  supplement). 
There is also a need for standardised and validated measures of duration of symptoms.
We found limited evidence that intensive education campaigns may lead to greater 
cancer awareness and earlier presentation over the short term. However, what exactly 
a campaign needs to include to make it work, to make it work over the longer term and 
in different settings, and to make it work cost-effectively are not clear and warrant more 
research. 
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 Figure 1. Flow of studies
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Outcome measure did not 
meet inclusion criteria (n=3)
Studies retrieved for detailed evaluation (n=90)
Studies included after initial evaluation (n=48)
Immediate follow-up (n=18)
Non-RCT (n=7)
Intervention not 
compared with 
usual care (n=5)
Community-level intervention 
studies (n=10)
Individual-level intervention 
studies (n=35)
Potentially relevant articles identified and abstracts screened for retrieval (n=2557)
Individual-level intervention 
studies (n=5)
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
(deNooijer 
et al, 2004)
Any cancer Tailored information delivered by post: 
Letter tailored to individual based on 
knowledge and intentions. Included 
information on cancer symptoms (for 
several cancers), reasons for early 
detection, risk, breast and testicular 
self-examination, screening 
programmes.
General information delivered by post: 
Brochure on early detection in several 
cancers used by Dutch Cancer 
Society.
RCT comparing:
• Individually 
tailored 
information vs 
• General 
information vs 
• No 
information
1331 adults (mean 
age 47, 80% 
women) without 
cancer recruited 
through 
newspaper 
adverts in 
Netherlands
Knowledge of cancer symptoms 
(range 0, 15) (3 weeks)
Attitude towards paying attention 
to symptoms (range -3, 3) (6 
months) 
Attitude towards seeking help for 
symptoms (range -3, 3) (6 months)
Higher in tailored information 
group vs general information 
group vs control (9.85 vs 9.26 vs 
8.21, p<0.001) 
Higher in tailored information 
group vs general information 
group vs control (2.05 vs 2.05 vs 
1.96, p<0.01)
Higher in tailored information 
group vs general information 
group vs control (2.13 vs 2.09 vs 
1.99, p<0.001)
+
(Rimer et al, 
2002)
Breast Tailored information delivered by post: 
Booklet about breast cancer risk, risk 
factors and mammography tailored to 
individual based on responses 
provided during telephone call. 
Reinforcing newsletter 12 months 
later.
Tailored information plus telephone 
counselling: As above plus 2 
telephone calls (1 after booklet and 1 
after newsletter) from trained health 
advisor asking questions about 
booklet/newsletter content to elicit 
questions and concerns.
RCT comparing:
• Tailored print 
materials vs 
• Tailored print 
materials plus 
telephone 
counselling vs
• Usual care
1091 women 
(aged 42-57) 
enrolled in health 
insurance plan in 
US
Knowledge that women aged >50 
at higher risk of breast cancer than 
younger women (24 months)
Higher in tailored print materials 
plus telephone counselling group 
vs tailored print materials group vs 
usual care (32% vs 26% vs 20%, 
p=0.001) 
+
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
(Glazebrook 
et al, 2006)
Melanoma Computer-based interactive 
educational programme to increase 
melanoma knowledge (including risk of 
sun exposure, how to protect skin, 
early signs) accessed through 
dedicated workstation in GP practice.
Cluster RCT (unit 
of randomisation = 
practice) 
comparing:
• Educational 
programme 
vs
• No 
programme
589 adults (mean 
age 38, 80% 
women) recruited 
from people with 
1+ risk factor for 
melanoma 
attending general 
practice in UK
Knowledge of how to reduce risk 
of melanoma, risk factors, 
symptoms (range 0, 12) (6 
months)
Higher in programme group vs no 
programme group (4.12 vs 3.36, 
p<0.001) 
++
Reference Cancer Intervention Design Participants Outcome (Time of 
measurement)
Results Quality of 
evidence
(see Appendix D)
(Boundouki 
et al, 2004)
Oral Leaflet to increase 
knowledge of oral cancer 
signs, risk factors and how 
to detect oral cancer, given 
out in waiting room.
Cluster RCT (unit 
of randomisation = 
session) 
comparing: 
• Leaflet vs
• No leaflet
316 adults (mean 
age 47, 59% 
women) attending 
dentist in UK
Knowledge of oral cancer (range 
0, 36) (8 weeks)
Higher in leaflet group vs no leaflet 
group (30.3 vs 29.0, p<0.001) 
+
(Wilt et al, 
2001)
Prostate Leaflet to increase knowledge about 
risks and benefits of early prostate 
cancer detection and treatment 
delivered by post.
RCT comparing:
• Leaflet vs
• No leaflet
550 men (mean 
age 72) attending 
a primary care 
centre in US 
Knowledge of natural history of 
untreated early prostate cancer (2 
weeks)
Knowledge that effectiveness of 
treatment in early prostate cancer 
is unknown (2 weeks)
No difference
Higher in leaflet group vs no leaflet 
group (56% vs 44%, p=0.04) 
  
+
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
 Table 2. Studies examining the effectiveness of community-level interventions on cancer awareness outcomes
Reference Cancer Intervention Design Population providing 
outcome data
Outcome Results 
(Blumenthal 
DS et al, 
2005)
Any cancer Public education campaign in 2 US 
cities (Nashville, Atlanta) to increase 
knowledge of several cancers in 
African-American communities, 
delivered by broadcast and print 
media, lectures, workshops, lectures, 
presentations over 18 months in 
1994-6.
Controlled study (non-
randomised) comparing: 
• Areas with black 
population in 
Nashville and Atlanta 
vs 
• Areas with black 
population in 2 cities 
receiving no 
campaign
African-American 
adults living in the 4 
cities approached by 
random digit dialling 
(4053 before 
intervention;
3914 after intervention)
Knowledge, beliefs and 
attitudes towards cancer 
risk factors and screening 
No difference. Quantitative data 
not provided.
(Skinner et  
al, 2000)
Breast Educational programme delivered in 
small groups by a health professional 
to 32 women (mainly African-
American) over three sessions, to 
increase breast cancer knowledge 
and screening uptake and promoting 
message dissemination to others in 
the social network.
Controlled study (non-
randomised)  in 1 US city 
(St Louis) comparing:
• 1 managed social 
network for low 
income elderly 
people receiving the 
programme vs
• 1 similar managed 
social network not 
receiving the 
programme 
153 women (mean age 
73) 99% African-
American, members of 
the social network 
provided data both 
before and after 
intervention
Knowledge of breast 
cancer symptoms, risk 
factors and risk (range 0, 
8) after 8 months
Higher in group education 
programme vs control networks 
4.1 vs 3.6, p<0.0001) 
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
(Kiekbusch 
et al, 2000)
Melanoma Interactive multimedia programme 
housed in kiosk in the centre of a 
village (in the pharmacy, then health 
centre, then library) to increase 
melanoma knowledge over 3 years.
Controlled study (non-
randomised) in Sweden 
comparing:
• 1 village receiving 
kiosk vs 
• 1 similar village not 
receiving kiosk
Swedish adults aged 
20-59 living in the 
villages recruited from 
population registries 
(648 before 
intervention;
604 after intervention)
Knowledge of melanoma 
symptoms, risk factors, 
risk, preventive measures 
(range 1, 3) at the end of 
intervention
No difference (kiosk village vs 
control village: 
Men: 2.70 vs 2.68, p-value not 
provided; 
women: 2.72 vs 2.75, p-value 
not provided)
(McCullagh 
et al, 2005)
Testicular Health promotion initiative with 
printed shower gel sachets, stickers 
and posters displayed in changing 
rooms in workplaces, health clubs 
and leisure centres, to increase 
knowledge of testicular cancer and 
promote self-examination, delivered 
once to each site.
Controlled study (non-
randomised) in the UK 
comparing:
• 10 sites receiving the 
health promotion 
initiative vs
• 4 sites receiving no 
health promotion 
initiative
Men aged 15-44 
attending workplaces, 
health clubs and 
leisure centres in UK 
(518 before 
intervention;
356 after intervention)
Knowledge of testicular 
cancer symptoms, risk and 
survival (range 0, 5) after 
6 weeks
Higher in health promotion 
initiative sites vs control sites (4 
vs 3, p=0.014) 
 Table 3. Studies examining the effectiveness of community-level interventions on early presentation outcomes
Reference Cancer Intervention Design Population providing 
outcome data
Outcome Results
(Catalano et  
al, 2003)
Breast 22 annual public education broadcast and 
print media campaigns in 3 US cities 
(Atlanta, Detroit, San Francisco) about 
nature, detection and treatment of breast 
cancer (Breast Cancer Awareness Month) 
over 1975-97.
Interrupted time-series 
analysis 
All cancer registrations in 
Atlanta, Detroit, San 
Francisco over 23 years
Additional in situ and local 
breast cancers
790 additional cancers 
over 23 years (p<0.05)
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
(Gabram et  
al, 2008)
Breast Educational presentations delivered to 
groups (mainly African-American) by 
community health advocates in churches, 
workplaces, schools etc, in 1 US city 
(Atlanta) to reduce breast cancer stage at 
presentation, during 2001-4.
Before-and-after study Women diagnosed with 
breast cancer (89% African-
American) in 1 Atlanta 
hospital in 2001 (n=113) and 
2004 (n=128)
Proportion with stage 0
Proportion with stage IV
Increased (12% vs 26%, 
p<0.005)
Reduced (17% vs 9%, 
p<0.05)
(MacKie et 
al, 2003)
Melanoma Public education campaign in West of 
Scotland to encourage early presentation in 
melanoma, delivered by posters and leaflets 
during 1986-8.
Before-and-after study Scottish people diagnosed 
with melanoma in one 
Glasgow clinic in 1986 
(n=125) and 2001 (n=162)
Proportion delaying 
presentation after 
symptom discovery 3 or 
fewer months
Proportion with tumour 
thickness <1.5mm
Increased (16% vs 67%, 
95% confidence interval 
for difference 42% to 
61%)
Increased (38% vs 72%, 
95% confidence interval 
for difference 23% to 
45%)
(Rossi et al, 
2000)
Melanoma Public education campaign in Padova, Italy 
with broadcast and print media campaign 
followed by leaflet about symptoms and risk 
factors for melanoma and skin self-
examination, inviting adults to request skin 
check, delivered by post to every family in 
Padova over 1991-6.
Before-and-after study Padova residents diagnosed 
with melanoma between 
1987-1990 (n=79) and 1991-
1996 (n=137)
Mean tumour thickness Reduced (2.0mm vs 1.5 
mm, p<0.02)
(Geczi et al, 
2001)
Testicular National Hungarian public education 
campaign about risk factors, importance of 
early detection and self-examination in 
testicular cancer, delivered by broadcast and 
print media and at events over 1995-8.
Before-and-after study Hungarian men diagnosed 
with testicular cancer in 1994 
(n=230) and 1998 (n=214) 
Time from symptom 
discovery to diagnosis 
No change
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Table 1. Studies examining the effectiveness of individual-level interventions
Reference Cancer Intervention Design Participants Outcome (time of 
measurement)
Results Quality of 
evidence (see 
Appendix D)
(Leander et 
al, 2007)
Retinoblastoma National Honduran public education 
campaign to increase awareness of early 
signs of retinoblastoma and to encourage 
early presentation, delivered by flyers, 
posters, broadcast and print media and 
seminars during 2003-5.
Before-and-after study Honduran children diagnosed 
with retinoblastoma in 1995-
2003 (n=59) and 2003- 2005 
(n=23)
Proportion presenting with 
advanced disease
Time from symptom 
discovery to diagnosis
Reduced (73% vs 35%, 
p=0.002)
No change
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Appendix A: Search Strategy 
Search 
number
Search Terms Results
1 (delay* or late or later or early or earlier or postpone* or wait* or deny or 
denial or promot*).mp (mp=ti,ot,ab,nm,hw,tc,id,sh,tn,dm,mf)
3 471 505
2 (helpseeking or diagnos* or present* or detect* or present* or attend* or 
consult* or seek or sought or refer or treatment or care).mp
12 653 832
3 (symptom* and (detect* or duration or onset*)).mp 233 071
4 (neoplasm* or cancer* or tumor or tumour or malignan*).mp 3 530 224
5 ((1 and 2) or 3) and 4 397 046
6 Health education.kf,sh,kw,id or “patient education as Topic”/ 132 915
7 6 and 4 11 986
8 7 or 5 406 275
9 Limit 8 to yr =”2000-2008” 217 118
10 Limit 9 to human (limit not valid in PsychInfo; records were retained) 195 231
11 (aware* or knowledge* or attitude* or recogni* or lay concept* or health 
belief* or expectation or information* or education*).mp
3 652 313
12 Randomized Controlled Trial/ or randomized controlled trial*.mp or 
randomised controlled trial.mp or controlled trial*.mp or intervention.mp or 
Intervention Studies/ or Research Design/ or comparative study.mp or 
program evaluation.mp or campaign.mp or educational program*.mp or 
(before and after).mp or controlled study.mp
5 908 672
13 10 and 11 and 12 11 017
14 Immunohistochemistry.mp or stroke.mp or exp nursing staff/ or exp 
medical errors/ or exp malpractice/ or exp liability, legal/ or exp disease 
models,animal/ or exp models, biological/ or models, animal/ or ((exp RNA, 
neoplasm/ or exp RNA, messenger/ or exp sequence analysis, RNA/ or 
exp RNA/ or exp signal transduction/ or transforming growth factor beta/ or 
exp DNA fragmentation/ or exp apoptosis/ or exp adenoviridae/ or exp 
genes/ or exp gene expression/ or exp cell communication/ pr exp 
antigens/ or exp alternative splicing/ or exp MicroRNAs/ or gene 
expression/ or exp membrane proteins/ or exp DNA-binding proteins/ or 
16 595 285
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intracellular signalling peptides.mp) and proteins.mp) or exp protein 
isoforms/ or exp proto-oncogene proteins/ or exp sequence analysis/ or 
exp glycosolation/ or exp chemistry, pharmaceutical/ or exp drug carriers/ 
or exp drug resistance/ or exp antineoplastic agents/ or exp toxicity tests/ 
or exp radiation oncology/ or exp cell transformation, neoplastic/ or exp 
mammary neoplasms, experimental/ or exp tumor stem cells/ or exp 
pathology/ or exp therapeutics, ae, mo, cl, nu, ct, px, ec, st, es, sn, hi, td, 
is, ut, mt, ve or (pa or ge or ch or ai or ut or ec or mjo or dt or pp or et or og 
or ah or du or im or su of tu or re or th or ad or is).fs
15 13 not 14 3 103
16 Remove duplicates from 15 2 759
17 Limit 16 to English language 2 561
Further duplicates found and removed 2 557
Included at abstract stage 90
Included at full text stage 48
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Appendix B: Inclusion/exclusion criteria
Individual level interventions: interventions delivered to identified individuals recruited to 
a  study  which  attempted  to  collect  outcome  data  from  those  individuals  after  the 
intervention.
Design: RCT
Population: Any, except if include only people at high genetic risk, health professionals 
only
Intervention: Individual level intervention aimed at increasing cancer awareness or early 
presentation
Comparator: Usual care, no intervention, placebo
Outcomes: Knowledge or beliefs about: 
• cancer symptoms
• risk of cancer
• cancer risk factors
• effectiveness of early treatment for cancer
• natural history or prognosis of cancer 
• what to look for in detecting a change that might be cancer
• attitude towards early detection behaviours and help-seeking
• confidence to detect a change that might be cancer
Time from symptom discovery to presentation or diagnosis; stage of disease 
at diagnosis; survival/mortality.
We excluded studies examining exclusively any of the following outcomes: 
• knowledge of checking behaviour techniques (for example, how to 
check breasts, testicles or skin)
• health-checking behaviour (for example, frequency of or competency 
in breast, testicular or skin self-examination) 
• knowledge of screening
• knowledge of or beliefs about nature of treatment for cancer
• intentions to take up screening
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• screening uptake 
We excluded studies with composite outcomes including the outcomes of 
interest, where these were not reported separately.
We also excluded studies where the only post-intervention outcome measure 
was taken on the same day the intervention was delivered.
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Community-level intervention: in which researchers did not control or identify which 
individual received the intervention
Design: RCT
Controlled study not using randomisation
Before and after studies
Time-series
Population: Any, except if include only people at high genetic risk, health professionals 
only
Intervention: Community-level intervention aimed at increasing cancer awareness or early 
presentation
Comparator: Usual care, no intervention, placebo
Outcomes: Knowledge or beliefs about: 
• cancer symptoms
• risk of cancer
• cancer risk factors
• effectiveness of early treatment for cancer
• natural history or prognosis of cancer 
• what to look for in detecting a change that might be cancer
• attitude towards early detection behaviours and help-seeking
• confidence to detect a change that might be cancer
Time from symptom discovery to presentation or diagnosis; stage of disease 
at diagnosis; survival/mortality.
 We excluded studies examining exclusively any of the following outcomes: 
• knowledge of checking behaviour techniques (for example, how to 
check breasts, testicles or skin)
• health-checking behaviour (for example, frequency of or competency 
in breast, testicular or skin self-examination) 
• knowledge of screening
• knowledge of or beliefs about nature of treatment for cancer
• intentions to take up screening
• screening uptake 
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We excluded studies with composite outcomes including the outcomes of 
interest, where these were not reported separately.
We also excluded studies where the only post-intervention outcome measure 
was taken on the same day the intervention was delivered.
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Appendix C:  Data Extraction Form 
1 Study ID  
1.1 ID number (reference manager ID)  
1.2 Reference  
1.3 1st reviewer  
1.4 Date of 1st review  
1.5 2nd reviewer  
1.6 Date of 2nd review  
2 STUDY  
2.1 Design  
2.2 Cancer site  
2.3 Method of participant selection  
2.4 Unit of randomisation  
2.5 Specific population  
2.6 Relevant data (i.e. the outcomes we are interested in - either cancer 
awareness or early presentation)
 
2.7 Objectives of intervention and paper  
2.8 Summary of intervention, outcome measures and findings  
3 PARTICIPANTS  
3.1 Country  
3.2 N=  
3.3 Age  
3.4 Gender  
3.5 Ethnicity  
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3.6 Marital status  
3.7 Education  
3.8 Experience of cancer  
3.9 Recruitment rate  
3.10. Attrition rate  
3.11 Income  
3.12 Other demog. Info  
4 METHODS  
4.1 Duration of study  
4.2 Theoretical basis of intervention  
4.3 Type of intervention  
4.4 Follow-up duration (time between intervention and follow-up)  
4.5 Time points for evaluation?  
4.6 Who delivers the intervention?  
4.7 How is intervention delivered?  
4.8 How many times is the intervention delivered?  
4.9 Which outcomes have been measured?  
4.10. How are outcomes assessed?  
4.11 If composite score, is it possible to extract relevant data?  
4.12 Validated measure (reference)  
4.13 Details of measure  
5 STATISTICAL ANALYSIS  
5.1 Statistical methods used  
6 RESULTS  
6.1 Knowledge of cancer symptoms  
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6.2 Knowledge of risk factors  
6.3 Knowledge of cancer incidence  
6.4 Knowledge of screening availability and purpose  
6.5 Time from symptom discovery to presentation  
6.6 Time from symptom discovery to diagnosis  
6.7 Size of tumour at diagnosis  
6.8 Grade of tumour diagnosis  
6.9 Survival
6.10. Differences in outcomes by age/gender/ethnicity/income/education/other  
6.11 Other relevant observations and conclusions  
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Appendix D:  Checklist for methodological quality of randomised studies
1.1 The study addresses an appropriate and 
clearly focused question
Well covered
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.2 The assignment of subjects to treatment 
groups is randomised
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.3 An adequate concealment method is 
used
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.4 Subjects and investigators are kept ‘blind’ 
about treatment allocation
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.5 The treatment and control groups are 
similar at the start of the trial
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.6 The only difference between groups is 
the intervention under investigation
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.7 All relevant outcomes are measured in a 
standard, valid and reliable way
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
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1.8 What percentage of the individuals or 
clusters recruited into each treatment arm 
of the study dropped out before the study 
was completed?
1.9 All the subjects are analysed in the 
groups to which they were randomly 
allocated (often referred to as intention to 
treat analysis)
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.10 Where the study is carried out at more 
than one site, results are comparable for 
all sites
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
1.11 An appropriate analysis was used for 
cluster randomised controlled trials
Well covered 
Adequately 
addressed
Poorly addressed
Not reported
Not applicable
The methodological quality of the study is rated based on your responses to the appropriate 
methodology checklist using the following coding system:
++ All or most of the criteria have been fulfilled. Where they have not been fulfilled the 
conclusions of the study are thought very unlikely to alter.
+ Some of the criteria have been fulfilled. Those criteria that have not been fulfilled or 
not adequately described are thought unlikely to alter the conclusions.
- Few or no criteria fulfilled. The conclusions of the study are thought likely or very likely 
to alter.
Notes:
1.1 Unless a clear and well defined question is specified, it will be difficult to assess how well 
the study has met its objectives or how relevant it is to the question you are trying to 
answer on the basis of its conclusions. Consider if the question is ‘focused’ in terms of the 
population studied, the intervention given and the outcomes chosen.
1.2 Random  allocation  of  patients  to  receive  one  or  other  of  the  treatments  under 
investigation,  or to receive either  treatment  or  placebo,  is  fundamental  to this  type of 
study. If the description of randomisation is poor, the study should be given a lower quality 
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rating.  Consider  the  following  points:  whether  the  randomisation  process  was  truly 
random, whether the method of allocation was described (stratification used to balance 
randomisation?), how the randomisation schedule was generated, how a participant was 
allocated to a study group and if  there were any differences reported that might have 
explained any outcome(s) (confounding).
1.3 Allocation  concealment  refers  to  the  process  used  to  ensure  that  researchers  are 
unaware which group patients are being allocated to at the time they enter the study. If 
the method of concealment used is regarded as poor, or relatively easy to subvert, the 
study should be given a lower quality rating. 
1.4 Blinding refers to the process whereby people are kept unaware of which treatment an 
individual  patient  has  been  receiving  when  they  are  assessing  the  outcome  for  that 
patient. The higher the level of blinding, the lower the risk of bias in the study. Consider 
the following points: the fact that blinding is not always possible, whether every effort was 
made to achieve blinding and ‘observer bias’.
1.5 Participants selected for inclusion in a trial must be as similar as possible.  The study 
should report any significant differences in the composition of the study groups in relation 
to gender mix, age, stage of disease (if appropriate), social background, ethnic origin, or 
comorbid conditions.  These factors may be covered by inclusion or  exclusion criteria, 
rather  than  being  reported  directly.  Failure  to  address  this  question,  or  the  use  of 
inappropriate groups, should lead to the study being downgraded. 
1.6 If some patients received additional intervention, even if of a minor nature or consisting of 
advice and counselling rather than a physical intervention, this treatment is a potential 
confounding factor that may invalidate the results. If groups were not treated equally, the 
study should be rejected unless no other evidence is available (if used as evidence it 
should be treated with caution).
1.7 The  primary  outcome  measures  used  should  be  clearly  stated  in  the  study.  Where 
outcome measures require any degree of subjectivity, some evidence should be provided 
that the measures used are reliable and have been validated prior to their use in the 
study. Considered whether participant outcomes were reviewed at the same time intervals 
and if they received the same amount of attention from researchers and health workers 
(any differences may introduce performance bias).
1.8 The number of participants that drop out of a study should give concern if the number is 
very high. Conventionally, a 20% drop out rate is regarded as acceptable, but this may 
vary. Some regard should be paid to why participants dropped out, as well as how many. 
It  should  be  noted  that  the  drop  out  rate  might  be  expected  to  be  higher  in  studies 
conducted  over  a  long  period  of  time.  A  higher  drop  out  rate  will  normally  lead  to 
downgrading, rather than rejection of a study.
1.9 It is rarely the case that all  participants allocated to the intervention group receive the 
intervention  throughout  the  trial,  or  that  all  those  in  the  comparison  group  do  not. 
However, participant outcomes must be analysed according to the group to which they 
were  originally  allocated  irrespective  of  the  intervention  that  they  actually  received 
(intention-to-treat analysis). The study may be rejected if it is clear that an intention-to-
treat analysis was not used.
1.10 In multi-site studies, confidence in the results should be increased if it can be shown that 
similar results were obtained at the different participating centres.
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1.11 The analysis chosen for cluster randomised controlled trials should be consistent with the 
design  –  it  should  take  clustering  into  account.  Valid  approaches  include:  analysing 
clustered  outcome  data  (unit  of  analysis  is  the  same  as  that  of  randomisation)  and 
individual level analysis accounting for clustering such as Random Effects Regression, 
Generalised Estimating Equations or Robust Standard Error. 
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